Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.

No abstract is available for this paper.

• Publication year

  1950

• Venue

  Journal of Clinical Investigation

• Publication date

  1950-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI102362PMID 14774471PMCID PMC436167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Raynaud's syndrome originating from reversible precipitation of protein.

  2009cited by this paper
• Cryoglobulinemia; report of two cases with discussion of clinical manifestations, incidence and significance.

  1950cited by this paper
• A STUDY OF RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA

  1950cited by this paper
• Changes in electrophoretic patterns of sera in patients with multiple myeloma treated with urethane

  1949cited by this paper
• Carbamates in the chemotherapy of leucemia; the distribution of radioactivity in tissues of mice following injection of carbonyl-labeled urethane.

  1949cited by this paper
• Carbamates in the chemotherapy of leukemia; the relationship between chemical structure and anti-leukemic action of a series of urethan derivatives.

  1949cited by this paper
• Urethane (ethyl carbamate) therapy in multiple myeloma.

  1949cited by this paper
• Cryoglobulinemia and raynaud's syndrome in a case of chronic lymphocytic leukemia

  1949cited by this paper
• The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease.

  1949cited by this paper
• A Note on the Amino Acid Content of Bence-Jones Protein.

  1949cited by this paper
• A cryoglobulin present in high concentration in the plasma of a case of multiple myeloma.

  1949cited by this paper
• Multiple myeloma; its clinical and laboratory diagnosis with emphasis on electrophoretic abnormalities.

  1949influential reference
• Raynaud's syndrome originating from reversible precipitation of protein

  1948cited by this paper
• Effect of urethane on malignant diseases; clinical, hematologic, and histologic observations on patients with carcinoma, leukemia and related diseases.

  1948cited by this paper
• Streptomycin-sensitive, -dependent, and -resistant Bacteria.

  1948cited by this paper
• Further studies on the effect of urethane on leucemia.

  1948cited by this paper
• Carbamates in the Chemotherapy of Leukemia. II. the Relationship Between Chemical Structure, Leukopenic Action, and Acute Toxicity of a Group of Urethan Derivatives

  1948cited by this paper
• Effect of urethane on malignant diseases; clinical, hematologic and histologic observations on patients with carcinoma, leukemia and related diseases.

  1948cited by this paper
• CARBAMATES IN THE CHEMOTHERAPY OF LEUKEMIA

  1948cited by this paper
• The plasma proteins in disease.

  1948influential reference
• Plasma cell myeloma associated with high concentration of plasma lipoprotein.

  1948cited by this paper
• [Not Available].

  1948cited by this paper
• The electrophoretic analysis of serum proteins of the blood dyscrasias.

  1948cited by this paper
• Multiple myeloma.

  1948cited by this paper
• Plasma cell myeloma associated with high concentration of plasma lipoprotein.

  1948cited by this paper
• Carbamates in the chemotherapy of leukemia; the relationship between chemical structure, leukopenic action, and acute toxicity of a group of urethan derivatives.

  1948cited by this paper
• A study of the plasma and tissue globulins in myelomatosis.

  1947cited by this paper
• Electrophoretic Studies on the Leukocytosis-Promoting Factor of Exudates.∗

  1947cited by this paper
• STUDIES OF CRYOGLOBULINS. I. UNUSUAL PURPURA ASSOCIATED WITH THE PRESENCE OF A HIGH CONCENTRATION OF CRYOGLOBULIN (COLD PRECIPITABLE SERUM GLOBULIN)

  1947cited by this paper
• Studies of cryoglobulins the spontaneous precipitation of protein from serum at 5 degrees C in various disease states.

  1947cited by this paper
• Primary systematized amyloidosis with macroglossia; a syndrome related to Bence-Jones proteinuria and myeloma.

  1947cited by this paper
• [Not Available].

  1947cited by this paper
• Primary systematized amyloidosis with macroglossia; a syndrome related to Bence Jones proteinuria and myeloma.

  1947cited by this paper
• Multiple myeloma; a review of 83 proved cases.

  1947cited by this paper
• MULTIPLE MYELOMA: A Review of Eighty-Three Proved Cases

  1947cited by this paper
• Recent advances in the study of biological competition between structurally related compounds.

  1947cited by this paper
• STUDIES OF CRYOGLOBULINS. II. THE SPONTANEOUS PRECIPITATION OF PROTEIN FROM SERUM AT 5° C IN VARIOUS DISEASE STATES

  1947cited by this paper
• A homomolecular serum protein with anomalous solubilities.

  1946cited by this paper
• Influence of Carbamic Esters (Urethanes) on Experimental Animal Tumours

  1946cited by this paper
• Studis on the Early Chang in the Livers of Rates Treated with Various Toxic Agents, with Especial Reference to the Vascular Lesions: I. The Histology of the Rat's Liver in Urethane Poisoning.

  1944cited by this paper
• The Detection of Urinary Bence Jones Protein

  1944cited by this paper
• ON THE PATHOGENESIS OF RENAL FAILURE ASSOCIATED WITH MULTIPLE MYELOMA. ELECTROPHORETIC AND CHEMICAL ANALYSIS OF PROTEIN IN URINE AND BLOOD SERUM.

  1944cited by this paper
• The Ultracentrifuge

  1943cited by this paper
• A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMA.

  1943cited by this paper
• BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA.

  1943influential reference
• Ein neues krystallinisches Serumglobulin

  1942cited by this paper
• The separation of an “activity” metabolism from the total respiration of yeast by the effects of Ethyl Carbamate

  1942cited by this paper
• An analysis of Bence-Jones protein.

  1941cited by this paper
• FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA.

  1941influential reference
• Immunological differences of crystalline Bence-Jones proteins.

  1940cited by this paper
• The serum proteins in multiple myelomatosis.

  1940cited by this paper
• Hyperproteinemia in multiple myeloma

  1938cited by this paper
• Über krystallisiertes und amorphes Bence Jones-Eiweiß, Multiple Myelome. IX.

  1936cited by this paper
• BENCE-JONES PROTEIN IN SERUM

  1934cited by this paper
• Renal Lesions Associated with Multiple Myeloma.

  1933cited by this paper
• HYPERPROTEINEMIA ASSOCIATED WITH MULTIPLE MYELOMAS: REPORT OF AN UNUSUAL CASE

  1928cited by this paper
• Specific immunological reactions of Bence-Jones proteins

  1921cited by this paper
• BENCE-JONES PROTEINURIA: SOME OBSERVATIONS ON ITS OCCURRENCE, WITH PARTICULAR REFERENCE TO NEPHRITIS AND HYPERTENSION

  1918cited by this paper
• A Case of Multiple Myelomata With Chronic Nephritis Showing Bence-Jones Protein in Urine and Blood Serum

  1917cited by this paper
• A study of Bence‐Jones protein, and of the metabolism in three cases of Bence‐Jones proteinuria

  1911cited by this paper
• Ueber das Vorkommen des Bence-Jonesschen Körpers im Harn bei Tumoren des Knochenmarks und seine diagnostische Bedeutung

  year unknowncited by this paper
• On a New Substance Occurring in the Urine of a Patient with Mollities Ossium.

  year unknowncited by this paper

• The evolution and impact of therapy in multiple myeloma

  2010cites this paper
• Serum gamma globulin in myelomatosis and other diseases with medullary plasmocytosis.

  2009cites this paper
• Urethane in Multiple Myeloma I

  2009cites this paper
• TURNOVER RATE OF PARAPROTEINS IN MYELOMATOSIS. STUDIES ON THE TURNOVER RATE OF SERUM PARAPROTEINS AFTER LABELLING IN VIVO, WITH SPECIAL REFERENCE TO REPEATED TURNOVER-RATE DETERMINATIONS.

  2009cites this paper
• Amyloid in Human Islets of Langerhans: Immunologic Evidence That Islet Amyloid Polypeptide Is Modified in Amyloidogenesis

  2000cites this paper
• Liver Disease from Surreptitious Administration of Urethane

  1993cites this paper
• The management of myelomatosis

  1987cites this paper
• Multiple myeloma.

  1980cites this paper
• [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].

  1979cites this paper
• Biology, Clinical Patterns, and Treatment of Multiple Myeloma and Related Plasma–Cell Dyscrasias

  1978cites this paper
• [Treatment of Kahler's disease].

  1976cites this paper
• The treatment of multiple myeloma.

  1973cites this paper
• Radiotherapeutic response of plasma cell tumors associated with monoclonal gammopathy

  1970cites this paper
• Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma.

  1967cites this paper
• The treatment of plasma cell myeloma.

  1967cites this paper
• Evaluation of Tryptophan Mustard (NSC-62403) in Patients with Plasmacytic Myeloma

  1967cites this paper
• Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma.

  1967cites this paper
• Current concepts in the therapy of multiple myeloma.

  1966cites this paper
• MULTIPLE MYELOMA. STUDIES OF MOUSE PLASMA CELL TUMOR AND HUMAN MYELOMA RESPONSIVENESS TO CYCLOPHOSPHAMIDE (CYTOXAN).

  1964cites this paper
• Melphalan Therapy in Myelomatosis

  1964cites this paper
• PROTEIN METABOLISM IN PATIENTS WITH MULTIPLE MYELOMA.

  1964cites this paper
• EVALUATION OF MELPHALAN (NSC-8806) IN TREATMENT OF MULTIPLE MYELOMA.

  1964cites this paper
• Multiple myeloma.

  1963cites this paper
• Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).

  1962cites this paper
• Criteria for Identification of Homogeneous Electrophoretic Peaks in Multiple Myeloma †

  1962cites this paper
• Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.

  1962cites this paper
• [The alteration of liver function and morphology by chemotherapy in hemoblastoses].

  1961cites this paper
• Plasma protein abnormalities in cancer.

  1961cites this paper
• [The modification of liver function by cytostatic therapy].

  1961cites this paper
• Clinical cancer chemotherapy.

  1961cites this paper
• Leukemia and lymphomata: status of current therapy.

  1961cites this paper
• [Hepatotoxic side-effects in cytostatic therapy].

  1961cites this paper
• A method for demonstrating probable synthesis of protein by bone marrow cells.

  1961cites this paper
• Chapter 17 – Alterations in Plasma Protein Patterns in Disease

  1960cites this paper
• Chapter 18 – Abnormal Serum Globulins

  1960cites this paper
• Leukemia: some present-day problems.

  1960cites this paper
• The significance of urine electrophoresis in patients with multiple myeloma.

  1960cites this paper
• Urethane-induced hepatic failure in man.

  1960cites this paper
• Plasma-cell myeloma. II. Clinical aspects.

  1959cites this paper
• A serologic and electrophoretic study of the malignant and proliferative disorders of the hematopoietic and reticuloendothelial systems.

  1959cites this paper
• Plasma-Cell Myeloma

  1959cites this paper
• THE FORMATION OF MYELOMA PROTEIN BY A MOUSE PLASMA CELL TUMOR

  1958cites this paper
• Multiple myeloma: diagnosis and management in a series of 57 cases.

  1957cites this paper
• Der heutige Stand der Chemotherapie neoplastischer Erkrankungen beim Menschen

  1957cites this paper
• Serum proteins in myelomatosis; a follow up study.

  1957cites this paper
• The management of multiple myeloma.

  1957cites this paper
• Die Elektrophorese bei inneren Krankheiten

  1957cites this paper
• [Present status of chemotherapy in human neoplastic diseases].

  1957cites this paper
• The palliative care of inoperable and incurable recrudescent neoplasms.

  1956cites this paper
• Macroglobulinemia and its relationship to other paraproteins; with a case report.

  1956cites this paper
• THE CARBOHYDRATE OF γ-GLOBULIN AND MYELOMA PROTEINS

  1956cites this paper
• Plasma cell myeloma; a clinical, pathologic and roentgenologic review of 90 cases.

  1955cites this paper
• Chemotherapy of human cancer.

  1955cites this paper
• Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma.

  1955cites this paper
• Toxic nephrosis and massive hepatic necrosis produced by urethan.

  1955cites this paper
• Abnormal serum and urine proteins in thirty five cases of multiple myeloma, as studied by filter paper electrophoresis.

  1955cites this paper
• Multiple myeloma: report of a case showing unusual remission lasting two years following severe hepatitis.

  1955cites this paper
• Cutaneous manifestations of multiple myeloma.

  1955cites this paper
• Proteins in multiple myeloma. III. Origin of Bence-Jones protein.

  1955cites this paper
• Cutaneous manifestations of multiple myeloma.

  1955cites this paper
• IMMUNOLOGICAL RELATIONSHIPS AMONG THE MYELOMA PROTEINS

  1955cites this paper
• Fulminating hepatic necrosis in a patient with multiple myeloma treated with urethane; report of case.

  1955cites this paper
• SECTION OF PHYSICS AND CHEMISTRY: CHEMOTHERAPY OF HUMAN CANCER*

  1955cites this paper
• Treatment of multiple myeloma.

  1954cites this paper
• Serum proteins in leukemia.

  1954cites this paper
• Filter paper electrophoretic patterns of serum in multiple myeloma.

  1954cites this paper
• Serum proteins in Hodgkin's disease and malignant lymphoma.

  1954cites this paper
• Serum proteins and lipoproteins in multiple myelomatosis.

  1954cites this paper
• Recurrent pneumonia in multiple myeloma and some observations on immunologic response.

  1954cites this paper
• Electrophoretic studies on the protein distribution in the serum of multiple myeloma patients.

  1953cites this paper
• Plasma proteins in cancer.

  1953cites this paper
• Recent contribution of electrophoresis to clinical pathology.

  1953cites this paper
• The estimation of gamma-globulins in normal and myelomatous plasmas by chemical fractionation.

  1953cites this paper
• Recent advances in the management of lymphomas and leukemias.

  1953cites this paper
• Neoplastic diseases.

  1952cites this paper
• [Chemotherapy of malignant tumors].

  1952cites this paper
• Urethane in multiple myeloma. I. Final report of a case treated more than four years with urethane.

  1952cites this paper
• An electrophoretic study on the origin of the abnormal plasma proteins in multiple myeloma.

  1952cites this paper
• Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.

  1951cites this paper
• The chemical control of cancer.

  1940cites this paper
• MULTIPLE MYELOMA

  1931cites this paper